相关实验视频
Updated: Feb 26, 2026

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.5K
不同的抗逆转录病毒疗法方案之间的差异改变了艾滋病毒感染者之间的切换模式
Hanxi Zhang1,2, Ye Su1,2, Yanping Yu2
1WHO Collaborating Centre for Comprehensive Management of HIV Treatment and Care, Beijing Ditan Hospital Capital Medical University, Beijing, China.
BMC public health
|February 24, 2026
概括
了解艾滋病毒感染者 (PLHIV) 的抗逆转录病毒疗法 (ART) 切换模式是关键. 患者的收入,年龄和教育影响了ART治疗方案的变化,强调了健康教育在优化治疗决策中的作用.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗逆转录病毒疗法 (ART) 改善了艾滋病毒感染者 (PLHIV) 的预期寿命.
- 患者教育和互联网接入赋予PLHIV在治疗决策中的权力.
- 了解ART切换模式可以指导有针对性的健康教育计划.
研究的目的:
- 调查PLHIV之间ART治疗方案切换的模式.
- 为了确定与患者驱动的与医生驱动的ART开关相关的因素.
- 探索社会经济和教育因素对ART转换行为的影响.
主要方法:
- 对1877名18岁以上接受ART的PLHIV患者进行横截面研究.
- 收集关于社会特征,ART转换模式和健康教育的数据.
- 多项式回归分析以确定与切换模式相关的因素.
主要成果:
- 34.04%的PLHIV转换了ART治疗方案;11.88%开始转换自己.
- 与转换相关的因素包括经济地位,年龄和参加教育讲座.
- 较低的收入 (<5000元) 与医生驱动的开关相关;年轻的年龄 (<30) 和稳定的工作与患者驱动的开关.
结论:
- 医疗环境中的健康教育可以促进积极的ART转换,并优化治疗决策.
- 量身定制的教育干预措施可以鼓励患者参与ART疗法选择.
- 了解患者的人口结构和社会经济因素对于有效的ART管理至关重要.
更多相关视频
相关概念视频
Retrovirus Life Cycles
50.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion
332
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
332
Dosage Regimen: Individualization
230
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
230
Retroviruses
15.1K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.1K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
312
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
312
Therapeutic Drug Monitoring: Affecting Factors
283
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
283

